Evidence map›Paper›PMID 40852473›Full record

ArticleAmerican journal of ophthalmology case reports2025

Therapeutic potential of allogeneic iPS cell-derived RPE transplantation for

Akiko Maeda, Daiki Sakai, Satoshi Yokota, Midori Yamamoto, Sunao Sugita, Yasuhiko Hirami, Michiko Mandai, Tadao Maeda, Masayo Takahashi, Yasuo Kurimoto

Abstract read
In one paragraph

Article in American journal of ophthalmology case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Akiko MaedaKobe City Eye Hospital, Japan.
Daiki SakaiKobe City Eye Hospital, Japan.
Satoshi YokotaKobe City Eye Hospital, Japan.
Midori YamamotoKobe City Eye Hospital, Japan.
Sunao SugitaKobe City Eye Hospital, Japan.
Yasuhiko HiramiKobe City Eye Hospital, Japan.
Michiko MandaiKobe City Eye Hospital, Japan.
Tadao MaedaKobe City Eye Hospital, Japan.
Masayo TakahashiKobe City Eye Hospital, Japan.
Yasuo KurimotoKobe City Eye Hospital, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: To evaluate the safety and therapeutic effects of induced pluripotent stem (iPS) cell-derived retinal pigment epithelium (RPE) transplantation for Observations: A 46-year-old male patient with Conclusions and importance: Although this case raised safety concerns regarding the use of cell suspension for RPE transplantation, RPE transplantation may still serve as a potential therapeutic option for patients with

Indexed as

Induced pluripotent stem (iPS) cellLeber congenital amaurosis (LCA)Regenerative medicineRPE65RPE transplantation

Identifiers

PMID40852473
PMCPMC12369432

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.